Publications related to outside publications | NDEWS l National Drug Early Warning System l University of Maryland

Krotulski, A.J., Mohr, A.L.A, Friscia, M., & Logan, B.K. (2018). Monitoring Changes in the Novel Psychoactive Substance (NPS) Market through Enhanced Identification of Emerging Drugs and their Metabolites in Biological Samples. National Criminal Justice Reference Service.
Lamy, F., Daniulaityte, R., Sheth, A., et al. (2018). eDark Trends update: New synthetic opioids, MPF-47,700, U-4TDP, U-48,800, U-49,900, and U-50,488 identified on two cryptomarkets. Wright State University. edarktrends_information_letter_1.pdf587.56 KB
National Academies of Sciences, Engineering, and Medicine. (2018). Public Health Consequences of E-Cigarettes. Washington, DC: The National Academies Press.
National Center on Addiction and Substance Abuse. (2018). Childhood Poisoning: Safeguarding Young Children from Addictive Substances.
National Forensic Laboratory Information System (NFLIS). (2018). NFLIS 2017 Mid-Year Report. US Department of Justice, Drug Enforcement Administration.
O'Donnell, J., Gladden, R.M., Mattson, C.L., & Kariisa, M. (2018). Overdose Deaths with Carfentanil and Other Fentanyl Analogs Detected — 10 States, July 2016–June 2017. MMWR Morbidity and Mortality Weekly Report, 67(27): 767-8.
Owens, P.L., Heslin, K.C., Fingar, K.R., & Weiss, A.J. (2018). Co-occurrence of Physical Health Conditions and Mental Health and Substance Use Conditions Among Adult Inpatient Stays, 2010 Versus 2014. United States Department of Health and Human Services,Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project.
Pham, T.T., Skrepnek, G.H., Bond, C., Alfieri, T., Cothran, T.J., & Keast, S.L. (2018). Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012–2016. Journal of Medical Care, 56(8): 727-35.
Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System, Inc. (2018). Increases in natural and semi-synthetic opioid deaths coincide with concurrent heroin and illicit fentanyl use. 2018 First Quarter Technical Report.
Saucier, R., Wolfe, D., & Dasgupta, N. (2018). Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. Drug Safety, published online ahead of print.Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence
Simpson, S., Adams, N., Brugman, C., Conners, T. (2018). Detecting Novel and Emerging Drug Terms Using Natural Language Processing: A Social Media Corpus Study. Journal of Medical Internet Research, Public Health and Surveillance, 4(1): e2.
Throckmorton, D.C., Gottlieb, S., & Woodcock, J. (2018). The FDA and the Next Wave of Drug Abuse — Proactive Pharmacovigilance. New England Journal of Medicine, Perspective.
Vivolo-Kanter, A.M., Seth, P., Gladden, R.M., Mattson, C.L., Baldwin, G.T., Kite-Powell, M., Coletta, M.A. (2018). Trends in Emergency Department Visits for Suspected Opioid Overdoses-United States, July 2016–September 2017. CDC MMWR Vital Signs.
Walker, R., Logan, T.K., Chipley, Q.T., & Miller, J. (2018). Characteristics and experiences of buprenorphine-naloxone use among polysubstance users. The American Journal of Drug and Alcohol Abuse, online.
Weaver, S.R., Huang, J., Pechacek, T.F., Heath, J.W., Ashley, D.L., & Eriksen, M.P. (2018). Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of U.S. adult smokers, 2015–2016. PLoS ONE 13(7):e0198047
Wish ED, Billing AS, Artigiani EE, Dezman Z, Schwartz B, Pueschel J. “Drug Early Warning from Re-Testing Biological Samples: Maryland Hospital Study." Office of National Drug Control Policy. Washington, DC: Executive Office of the President. July 2018
Wood, E. (2018). Strategies for Reducing Opioid-Overdose Deaths — Lessons from Canada. New England Journal of Medicine, 378:1565-7.
The Blue Lotus Flower (Nymphea caerulea) Resin Used in a New Type of Electronic Cigarette, the ReBuildable Dripping Atomizer Justin L. Poklis B.S., Haley Mulder B.S., Matthew Halquist Ph.D., Carl Wolf Ph.D., Alphonse Poklis Ph.D., Michelle R. Peace Ph.D.
Bechteler, S.S. & Kane-Willis, K. (2017). Whitewashed: The African American Opioid Crisis. Chicago Urban League, Research and Policy Center.
Billing, A.S., Artigiani, E.E., Robinson, J., Adatsi, F., & Wish, E.D. (2017). Community Drug Early Warning System (CDEWS-3): Washington, DC – Site 3 of 4. Office of National Drug Control Policy. Washington, DC: Executive Office of the President. finalreport_cdews3_dc_v56.pdf660.51 KB
Dowell, D., Noonan, R.K., & Houry, D. (2017). Underlying Factors in Drug Overdose Deaths. JAMA, 318(23): 2295-6.
European Monitoring Centre for Drugs and Drug Addiction. (2017). Health and social responses to drug problems: a European guide.
Evoy, K.E., Morrison, M.D., & Saklad, S.R. (2017). Abuse and Misuse of Pregabalin and Gabapentin. Drugs, 77(4):403-26.
Falkowski, C. (2017). Drug Abuse Trends in the Minneapolis/St. Paul Metropolitan Area. Minnesota Prevention Resource Center. St. Paul, MN. 2017_april_drug_abuse_trends_twin_cities.pdf763.08 KB
Gorman, A. (2017). Kenney Launches Task Force to Fight Opioid Crisis in Philadelphia. 6ABC.